Mycobacterium biofilms: Factors involved in development, dispersal, and therapeutic strategies against biofilm-relevant pathogens

Critical Reviews in Eukaryotic Gene Expression

Volumn 24, Issue 3, 2014, Pages 269-279

  Xiang, Xiaohong ^b   Deng, Wanyan ^b   Liu, Minqiang ^b   Xie, Jianping ^a  

^a SOUTHWEST UNIVERSITY   (China)

^b NONE

Author keywords

Antibiotics; Biofifilm; Development; Dispersal; Drug target; Mycobacterium; Resistance; Tuberculosis

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; CARBON DIOXIDE; CLARITHROMYCIN; CYCLOSERINE; GLYCOPEPTIDOLIPID; ISONIAZID; LIPID; MOXIFLOXACIN; MYCOLIC ACID; POLYADENYLIC ACID; POLYSORBATE 80; PROLINE; RIFAMPICIN; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG; GLYCOPEPTIDE;

ANTIBIOTIC RESISTANCE; ARTICLE; BIOFILM; CELL SURFACE; DRUG TARGETING; HUMAN; LIPOGENESIS; MYCOBACTERIUM; MYCOBACTERIUM AVIUM; MYCOBACTERIUM BOVIS; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REGULATORY MECHANISM; TUBERCULOSIS; WATER VAPOR; BACTERIUM ADHERENCE; CELL WALL; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; TUBERCULOSIS, PULMONARY;

ANTITUBERCULAR AGENTS; BACTERIAL ADHESION; BIOFILMS; CELL WALL; GLYCOPEPTIDES; HUMANS; MYCOBACTERIUM TUBERCULOSIS; OXIDATIVE STRESS; TUBERCULOSIS, PULMONARY;

EID: 84902688870     PISSN: 10454403     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevEukaryotGeneExpr.2014010545     Document Type: Article

References (60)

1. Whitchurch CB, Tolker-Nielsen T, Ragas PC, Mattick JS. Extracellular DNA required for bacterial biofilm formation. Science. 2002 Feb 22;295(5559):1487. PubMed PMID: 11859186. Epub 2002/02/23. eng.
2. Karatan E, Watnick P. signals, regulatory networks, and materials that build and break bacterial biofilms. Microbiol Molec Biol Revs. 2009;73(2):310-47.
3. Falkinham JO. Growth in catheter biofilms and antibiotic resistance of Mycobacterium avium. J Med Microbiol. 2007;56(2):250-4.
4. Bosio S, Leekha S, Gamb SI, Wright AJ, Terrell CL, Miller DV. Mycobacterium fortuitum prosthetic valve endocarditis: a case for the pathogenetic role of biofilms. Cardiovasc Pathol. 2012;21(4):361-4.
5. Carter G, Young LS, Bermudez LE. A subinhibitory concentration of clarithromycin inhibits Mycobacterium avium biofilm formation. Antimicrobial Agents Chemotherapy. 2004;48(12):4907-10.
6. Karatan E, Watnick P. Signals, regulatory networks, and materials that build and break bacterial biofilms. Microbiol Molec Biol Revs. 2009 Jun;73(2):310-47. PubMed PMID: 19487730. Pubmed Central PMCID: 2698413.
7. Falkinham JO, Norton CD, LeChevallier MW. Factors influencing numbers of Mycobacterium avium, Mycobacterium intracellulare, and other mycobacteria in drinking water distribution systems. Appl Environ Microbiol. 2001;67(3):1225-31.
8. Komor U, Bielecki P, Loessner H, Rohde M, Wolf K, Westphal K, Weiss S, Häussler S. Biofilm formation by Pseudomonas aeruginosa in solid murine tumors-a novel model system. Microbes Infect. 2012 Sep;14(11):951-8. PubMed PMID: 22542841. Epub 2012/05/01. eng.
9. He H, Cooper JN, Mishra A, Raskin DM. Stringent response regulation of biofilm formation in Vibrio cholerae. J Bacteriol. 2012 Jun;194(11):2962-72. PubMed PMID: 22467780. Pubmed Central PMCID: 3370634. Epub 2012/04/03. eng.
10. Hall-Stoodley L, Stoodley P. Biofilm formation and dispersal and the transmission of human pathogens. Trends Microbiol. 2005;13(1):7-10.
11. Pang JM, Layre E, Sweet L, Sherrid A, Moody DB, Ojha A, Sherman DR. The polyketide Pks1 contributes to biofilm formation in Mycobacterium tuberculosis. J Bacteriology. 2011;194(3):715-21.
12. Kulka K, Hatfull G, Ojha AK. Growth of Mycobacterium tuberculosis biofilms. J Vis Exp. 2012 (60). PubMed PMID: 22371116. Epub 2012/03/01. eng.
13. Carter G. Characterization of biofilm formation by clinical isolates of Mycobacterium avium. J Med Microbiol. 2003;52(9):747-52.
14. Gopalaswamy R, Narayanan S, Jacobs WR, Av-Gay Y. Mycobacterium smegmatis biofilm formation and sliding motility are affected by the serine/threonine protein kinase PknF. FEMS Microbiol Lett. 2008;278(1):121-7.
15. Poole K. Stress responses as determinants of antimicrobial resistance in Gram-negative bacteria. Cell. 2012;20(5):227-34.
16. Marsollier L, Brodin P, Jackson M, Korduláková J, Tafelmeyer P, Carbonnelle E, Aubry J, Milon G, Legras P, André JP, Leroy C, Cottin J, Guillou ML, Reysset G, Cole ST. Impact of mycobacterium ulcerans biofilm on transmissibility to ecological niches and buruli ulcer pathogenesis. PLoS Pathogens. 2007;3(5):e62.
17. Hall-Stoodley L, Keevil CW, Lappin-Scott HM. Mycobacterium fortuitum and Mycobacterium chelonae biofilm formation under high and low nutrient conditions. J Appl Microbiol. 1998 Dec;85 Suppl 1:60S-9S. PubMed PMID: 21182694. Epub 1998/12/01. eng.
18. Costerton JW, Lewandowski Z, Caldwell DE, Korber DR, Lappin-Scott HM. Microbial biofilms. Annu Rev Microbiol. 1995;49:711-45. PubMed PMID: 8561477. Epub 1995/01/01. eng.
19. Yamazaki Y, Danelishvili L, Wu M, MacNab M, Bermudez LE. Mycobacterium avium genes associated with the ability to form a biofilm. Appl Environ Microbiol. 2006;72(1):819-25.
20. Teng R, Dick T. Isoniazid resistance of exponentially growing Mycobacterium smegmatis biofilm culture. FEMS Microbiol Lett. 2003;227(2):171-4.
21. Ojha AK, Baughn AD, Sambandan D, Hsu T, Trivelli X, Guerardel Y, Alahari A, Kremer L, Jacobs WR Jr, Hatfull GF. Growth of Mycobacterium tuberculosis biofilms containing free mycolic acids and harbouring drug-tolerant bacteria. Molecular Microbiol. 2008;69(1):164-74.
22. Arora K, Whiteford DC, Lau-Bonilla D, Davitt CM, Dahl JL. Inactivation of lsr2 results in a hypermotile phenotype in mycobacterium smegmatis. J Bacteriology. 2008;190(12):4291-300.
23. Recht J, Kolter R. Glycopeptidolipid acetylation affects sliding motility and biofilm formation in Mycobacterium smegmatis. J Bacteriology. 2001;183(19):5718-24.
24. Ortalo-Magne A, Lemassu A, Laneelle MA, Bardou F, Silve G, Gounon P, Marchal G, Daffé M. Identification of the surface-exposed lipids on the cell envelopes of Mycobacterium tuberculosis and other mycobacterial species. J Bacteriol. 1996 Jan;178(2):456-61. PubMed PMID: 8550466. Pubmed Central PMCID: 177678. Epub 1996/01/01. eng.
25. Chen JM, German GJ, Alexander DC, Ren H, Tan T, Liu J. Roles of Lsr2 in colony morphology and biofilm formation of Mycobacterium smegmatis. J Bacteriology. 2005;188(2):633-41.
26. Wu C-w, Schmoller SK, Bannantine JP, Eckstein TM, Inamine JM, Livesey M, Albrecht R, Talaat AM. A novel cell wall lipopeptide is important for biofilm formation and pathogenicity of Mycobacterium avium subspecies paratuberculosis. Microbial Pathogenesis. 2009;46(4):222-30.
27. Martinez A, Torello S, Kolter R. Sliding motility in mycobacteria. J Bacteriol. 1999 Dec;181(23):7331-8. PubMed PMID: 10572138. Pubmed Central PMCID: 103697. Epub 1999/11/26. eng.
28. Howard ST, Rhoades E, Recht J, Pang X, Alsup A, Kolter R, Lyons CR, Byrd TF. Spontaneous reversion of Mycobacterium abscessus from a smooth to a rough morphotype is associated with reduced expression of glycopeptidolipid and reacquisition of an invasive phenotype. Microbiol. 2006 Jun;152(Pt 6):1581-90. PubMed PMID: 16735722. Epub 2006/06/01. eng.
29. Chandra H, Basir SF, Gupta M, Banerjee N. Glutamine synthetase encoded by glnA-1 is necessary for cell wall resistance and pathogenicity of Mycobacterium bovis. Microbiol. 2010;156(12):3669-77.
30. Harth G, Masleša-Galić S, Tullius MV, Horwitz MA. All four Mycobacterium tuberculosis glnA genes encode glutamine synthetase activities but only GlnA1 is abundantly expressed and essential for bacterial homeostasis. Molecular Microbiol. 2005;58(4):1157-72.
31. Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE 3rd, Tekaia F, Badcock K, Basham D, Brown D, Chillingworth T, Connor R, Davies R, Devlin K, Feltwell T, Gentles S, Hamlin N, Holroyd S, Hornsby T, Jagels K, Krogh A, McLean J, Moule S, Murphy L, Oliver K, Osborne J, Quail MA, Rajandream MA, Rogers J, Rutter S, Seeger K, Skelton J, Squares R, Squares S, Sulston JE, Taylor K, Whitehead S, Barrell BG. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 1998 Jun 11;393(6685):537-44. PubMed PMID: 9634230. Epub 1998/06/20. eng.
32. Garnier T, Eiglmeier K, Camus JC, Medina N, Mansoor H, Pryor M, Duthoy S, Grondin S, Lacroix C, Monsempe C, Simon S, Harris B, Atkin R, Doggett J, Mayes R, Keating L, Wheeler PR, Parkhill J, Barrell BG, Cole ST, Gordon SV, Hewinson RG. The complete genome sequence of Mycobacterium bovis. Proc Natl Acad Sci USA. 2003 Jun 24;100(13):7877-82. PubMed PMID: 12788972. Pubmed Central PMCID: 164681. Epub 2003/06/06. eng.
33. Ojha A, Anand M, Bhatt A, Kremer L, Jacobs WR, Hatfull GF. GroEL1: A dedicated chaperone involved in mycolic acid biosynthesis during biofilm formation in mycobacteria. Cell. 2005;123(5):861-73.
34. Barry CE 3rd, Lee RE, Mdluli K, Sampson AE, Schroeder BG, Slayden RA, Yuan Y. Mycolic acids: structure, biosynthesis and physiological functions. Prog Lipid Res. 1998 Jul-Aug;37(2-3):143-79. PubMed PMID: 9829124. Epub 1998/11/26. eng.
35. Vilcheze C, Wang F, Arai M, Hazbon MH, Colangeli R, Kremer L, Weisbrod TR, Alland D, Sacchettini JC, Jacobs WR Jr. Transfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid. Nat Med. 2006 Sep;12(9):1027-9. PubMed PMID: 16906155. Epub 2006/08/15. eng.
36. Ojha AK, Trivelli X, Guerardel Y, Kremer L, Hatfull GF. Enzymatic hydrolysis of trehalose dimycolate releases free mycolic acids during mycobacterial growth in biofilms. J Biological Chem. 2010;285(23):17380-9.
37. Ramaswamy SV, Reich R, Dou SJ, Jasperse L, Pan X, Wanger A, Quitugua T, Graviss EA. Single nucleotide polymorphisms in genes associated with isoniazid resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2003 Apr;47(4):1241-50. PubMed PMID: 12654653. Pubmed Central PMCID: 152487. Epub 2003/03/26. eng.
38. van Pittius NCG, Sampson SL, Lee H, Kim Y, Van Helden PD, Warren RM. Evolution and expansion of the Mycobacterium tuberculosis PE and PPE multigene families and their association with the duplication of the ESAT-6 (esx) gene cluster regions. BMC Evolutionary Biology. 2006;6(1):95.
39. Dong D, Wang D, Li M, Wang H, Yu J, Wang C, Liu J, Gao Q. PPE38 modulates the innate immune response and is required for mycobacterium marinum virulence. Infection Immunity. 2011;80(1):43-54.
40. Ojha A, Hatfull GF. The role of iron in Mycobacterium smegmatis biofilm formation: the exochelin siderophore is essential in limiting iron conditions for biofilm formation but not for planktonic growth. Molecular Microbiol. 2007;66(2):468-83.
41. Mathew R, Ramakanth M, Chatterji D. Deletion of the gene rpoZ, encoding the omega subunit of RNA polymerase, in Mycobacterium smegmatis results in fragmentation of the beta' subunit in the enzyme assembly. J Bacteriol. 2005 Sep;187(18):6565-70. PubMed PMID: 16159791. Pubmed Central PMCID: 1236636. Epub 2005/09/15. eng.
42. Mukherjee R, Chatterji D. Proteomics and mass spectrometric studies reveal planktonic growth of Mycobacterium smegmatis in biofilm cultures in the absence of rpoZ. J Chromatography B. 2008;861(2):196-202.
43. Deol P, Vohra R, Saini AK, Singh A, Chandra H, Chopra P, Das TK, Tyagi AK, Singh Y. Role of Mycobacterium tuberculosis Ser/Thr Kinase PknF: Implications in glucose transport and cell division. J Bacteriology. 2005;187(10):3415-20.
44. Schorey JS, Sweet L. The mycobacterial glycopeptidolipids: structure, function, and their role in pathogenesis. Glycobiology. 2008;18(11):832-41.
45. Shin SJ, Wu CW, Steinberg H, Talaat AM. Identification of novel virulence determinants in Mycobacterium paratuberculosis by screening a library of insertional mutants. Infect Immun. 2006 Jul;74(7):3825-33. PubMed PMID: 16790754. Pubmed Central PMCID: 1489745. Epub 2006/06/23. eng.
46. Röse L, Kaufmann SHE, Daugelat S. Involvement of Mycobacterium smegmatis undecaprenyl phosphokinase in biofilm and smegma formation. Microbes Infection. 2004;6(11):965-71.
47. Sonden B, Kocincova D, Deshayes C, Euphrasie D, Rhayat L, Laval F, Laval F, Frehel C, Daffé M, Etienne G, Reyrat JM. Gap, a mycobacterial specific integral membrane protein, is required for glycolipid transport to the cell surface. Mol Microbiol. 2005 Oct;58(2):426-40. PubMed PMID: 16194230.
48. Bourai N, Jacobs WR, Narayanan S. Deletion and overexpression studies on DacB2, a putative low molecular mass penicillin binding protein from Mycobacterium tuberculosis H37Rv. Microbial Pathogenesis. 2012;52(2):109-16.
49. Geier H, Mostowy S, Cangelosi GA, Behr MA, Ford TE. Autoinducer-2 triggers the oxidative stress response in mycobacterium avium, leading to biofilm formation. Appl Environ Microbiol. 2008;74(6):1798-804.
50. Esteban J, Martín-de-Hijas NZ, Kinnari TJ, Ayala G, Fernández-Roblas R, Gadea I. Biofilm development by potentially pathogenic non-pigmented rapidly growing mycobacteria. BMC Microbiology. 2008;8(1):184.
51. Chawla M, Parikh P, Saxena A, Munshi M, Mehta M, Mai D, Srivastava AK, Narasimhulu KV, Redding KE, Vashi N, Kumar D, Steyn AJ, Singh A. Mycobacterium tuberculosis WhiB4 regulates oxidative stress response to modulate survival and dissemination in vivo. Mol Microbiol. 2012 Sep;85(6):1148-65. PubMed PMID: 22780904. Pubmed Central PMCID: 3438311. Epub 2012/07/12. eng.
52. Kolodkin-Gal I, Cao S, Chai L, Böttcher T, Kolter R, Clardy J, Losick R. A self-produced trigger for biofilm disassembly that targets exopolysaccharide. Cell. 2012;149(3):684-92.
53. Toutain-Kidd CM, Kadivar SC, Bramante CT, Bobin SA, Zegans ME. Polysorbate 80 inhibition of pseudomonas aeruginosa biofilm formation and its cleavage by the secreted Lipase LipA. Antimicrobial Agents Chemotherapy. 2008;53(1):136-45.
54. Kolodkin-Gal I, Romero D, Cao S, Clardy J, Kolter R, Losick R. D-amino acids trigger biofilm disassembly. Science. 2010;328(5978):627-9.
55. Brennan P. the envelope of mycobacteria. Annu Rev Biochem 1995;64:29-63.
56. Shunsuke Ishida, Masayoshi Arai, Hiroki Niikawa, Kobayashi M. Inhibitory effect of cyclic trihydroxamate siderophore, desferrioxamine E, on the biofilm formation of Mycobacterium species. Biol Pharm Bull 2011;6(34):917-20.
57. Arai M, Niikawa H, Kobayashi M. Marine-derived fungal sesterterpenes, ophiobolins, inhibit biofilm formation of Mycobacterium species. J Natural Medicines. 2012.
58. Song L, Wu J, Xi C. Biofilms on environmental surfaces: evaluation of the disinfection efficacy of a novel steam vapor system. Am J Infection Control. 2012 Dec;40(10):926-30. PubMed PMID: 22418602.
59. Pawlowski A, Jansson M, Skold M, Rottenberg ME, Kallenius G. Tuberculosis and HIV co-infection. PLoS Pathog. 2012 Feb;8(2):e1002464. PubMed PMID: 22363214. Pubmed Central PMCID: 3280977. Epub 2012/03/01. eng.
60. Noor R, Akhter S, Rahman F, Munshi SK, Kamal SM, Feroz F. Frequency of extensively drug-resistant tuberculosis (XDR-TB) among re-treatment cases in NIDCH, Dhaka, Bangladesh. J Infect Chemother. 2012 Oct 10. PubMed PMID: 23053506. Epub 2012/10/12. Eng.